Hrib; Nicholas J

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hrib; Nicholas J.The latest application filed is for "interleukin-4 gene expression inhibitors".

Company Profile

0.8.5

Hrib; Nicholas J - Hillsborough NJ
HRIB; Nicholas J. - Hillsborough NJ
Hrib; Nicholas J. - Somerville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D.sub.4 antagonists Grant 7,511,046 - Fink , et al. March 31, 2	2009-03-31
Interleukin-4 Gene Expression Inhibitors App 20080132481 - ALKAN; Sefik S. ; et al.	2008-06-05
Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D.sub.4 antagonists Grant 7,253,165 - Shutske , et al. August 7, 2	2007-08-07
Indole derivatives as interleukin-4 gene expression inhibitors Grant 7,169,925 - Merriman , et al. January 30, 2	2007-01-30
Thienoisoxazolyl-and Thienylpyrrazolyl Phenoxy Substituted Propyl Derivatives Useful As D4 Antagonists App 20070004695 - Fink; David M. ; et al.	2007-01-04
Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D.sub.4 antagonists Grant 7,125,903 - Fink , et al. October 24, 2	2006-10-24
Benzisoxazolyl-,pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists App 20050107377 - Shutske, Gregory M. ; et al.	2005-05-19
Indole derivatives as interleukin -4 gene expression inhibitors App 20040010029 - Merriman, Gregory H. ; et al.	2004-01-15
Interleukin-4 gene expression inhibitors App 20040006123 - Alkan, Sefik S. ; et al.	2004-01-08
4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof Grant 5,880,121 - Hrib March 9, 1	1999-03-09
3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds Grant 5,229,388 - Hrib , et al. July 20, 1	1993-07-20
Benzoisothiazole- and benziosoxazole-3-carboxamides Grant 5,143,923 - Hrib , et al. September 1, 1	1992-09-01
3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles Grant 5,041,445 - Hrib , et al. August 20, 1	1991-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.